spot_img
19.1 C
London
HomeTOP STORIESAmgen outlines $37B–$38.4B 2026 revenue target as Repatha, EVENITY, and TEZSPIRE drive...

Amgen outlines $37B–$38.4B 2026 revenue target as Repatha, EVENITY, and TEZSPIRE drive momentum

Post Content 

spot_img

latest articles

explore more